{"id":53197,"date":"2025-09-16T12:38:34","date_gmt":"2025-09-16T16:38:34","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/corporate-shifts-and-global-tensions-mark-mid-september-news\/53197\/"},"modified":"2025-09-16T12:38:34","modified_gmt":"2025-09-16T16:38:34","slug":"corporate-shifts-and-global-tensions-mark-mid-september-news","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/corporate-shifts-and-global-tensions-mark-mid-september-news\/53197\/","title":{"rendered":"Corporate Shifts and Global Tensions Mark Mid-September News"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Eli Lilly (<a href=\"\/stock\/LLY\">LLY<\/a>)<\/strong> is actively combating the proliferation of fake and compounded versions of its popular weight-loss and diabetes drugs, <strong>Mounjaro<\/strong> and <strong>Zepbound<\/strong>, issuing warnings against misleading advertisements and unsafe online sales.<\/li>\n<li><strong>Nestl\u00e9 (<a href=\"\/stock\/NSRGY\">NSRGY<\/a>)<\/strong> is undergoing a significant leadership transition as long-serving Chairman <strong>Paul Bulcke<\/strong> prepares to step down, with <strong>Pablo Isla<\/strong> slated to assume the role on <strong>October 1<\/strong>.<\/li>\n<li>European Trade Commissioner <strong>Maro\u0161 \u0160ef\u010dovi\u010d<\/strong> is set to visit Indonesia on <strong>September 23<\/strong> to sign a landmark Comprehensive Economic Partnership Agreement (CEPA), marking the culmination of nine years of negotiations.<\/li>\n<li>UN Secretary-General <strong>Ant\u00f3nio Guterres<\/strong> has described the situation in Gaza as &quot;horrendous&quot; and &quot;morally, politically and legally intolerable,&quot; while expressing willingness to meet Israeli Prime Minister <strong>Benjamin Netanyahu<\/strong> if requested.<\/li>\n<\/ul>\n<h2>Eli Lilly Battles Counterfeit Drug Market<\/h2>\n<p>Pharmaceutical giant <strong>Eli Lilly (<a href=\"\/stock\/LLY\">LLY<\/a>)<\/strong> is taking strong measures to address the growing issue of counterfeit and compounded versions of its highly sought-after medications, <strong>Mounjaro<\/strong> and <strong>Zepbound<\/strong>. The company has issued public warnings concerning misleading advertisements and the unsafe sale of unauthorized products online and through various channels, including some med-spas.<\/p>\n<p><strong>Eli Lilly<\/strong> emphasizes that its FDA-approved tirzepatide medicines, <strong>Mounjaro<\/strong> (for type 2 diabetes) and <strong>Zepbound<\/strong> (for obesity), are not approved for cosmetic weight loss or for individuals under 18 years of age. The company has identified fake products that mimic its genuine offerings, and tests have revealed these counterfeits can contain incorrect dosages, impurities, bacteria, or even no active medicine at all. <strong>Eli Lilly<\/strong> is actively pursuing legal action against entities selling these unauthorized versions, underscoring its commitment to patient safety and the integrity of its brand.<\/p>\n<h2>Nestl\u00e9 Announces Chairman Succession<\/h2>\n<p><strong>Nestl\u00e9 (<a href=\"\/stock\/NSRGY\">NSRGY<\/a>)<\/strong>, the global food and beverage conglomerate, is preparing for a significant change in its top leadership. Current Chairman <strong>Paul Bulcke<\/strong> has decided to step down from his position, with <strong>Pablo Isla<\/strong> appointed as his successor. The transition is scheduled to become effective on <strong>October 1<\/strong>.<\/p>\n<p><strong>Bulcke<\/strong>, who has had a distinguished career spanning nearly half a century with <strong>Nestl\u00e9<\/strong>, including eight years as CEO and nine years as chairman, expressed full trust in the company&#39;s new leadership. <strong>Pablo Isla<\/strong>, formerly the CEO of Spanish fashion giant Inditex, has been a member of <strong>Nestl\u00e9&#39;s<\/strong> board since 2018 and has served as Vice Chairman. This leadership shift aims to bring a fresh perspective to advance <strong>Nestl\u00e9&#39;s<\/strong> strategy and guide the company into its next chapter.<\/p>\n<h2>EU and Indonesia Set to Ink Major Trade Deal<\/h2>\n<p>European Trade Commissioner <strong>Maro\u0161 \u0160ef\u010dovi\u010d<\/strong> is slated to travel to Indonesia on <strong>September 23<\/strong> to formalize a Comprehensive Economic Partnership Agreement (CEPA). This landmark agreement follows nine years of intensive negotiations aimed at boosting trade and investment between the European Union and Indonesia.<\/p>\n<p>A political agreement on the CEPA was reached on <strong>July 13, 2025<\/strong>, between European Commission President Ursula Von der Leyen and Indonesian President Prabowo Subianto. The pact is expected to eliminate trade barriers and foster a more predictable and inclusive business environment, significantly enhancing economic ties between the two blocs. Indonesia&#39;s Coordinating Minister for Economic Affairs, Airlangga Hartarto, highlighted the agreement&#39;s importance amid uncertain global economic conditions.<\/p>\n<h2>UN Chief Condemns Gaza Situation, Open to Meeting Netanyahu<\/h2>\n<p>UN Secretary-General <strong>Ant\u00f3nio Guterres<\/strong> has voiced strong condemnation of the situation in Gaza, describing it as &quot;horrendous&quot; and warning of &quot;systematic destruction&quot;. He further characterized the ongoing conflict as &quot;morally, politically and legally intolerable&quot;.<\/p>\n<p>In related developments, <strong>Guterres<\/strong> indicated his willingness to meet with Israeli Prime Minister <strong>Benjamin Netanyahu<\/strong> at the UN next week, should such a request be made. This comes amid reports that <strong>Netanyahu<\/strong> has not taken <strong>Guterres&#39;s<\/strong> calls since October 7. A UN Commission of Inquiry also released a report concluding that Israel has committed genocide in Gaza, citing high-level Israeli officials for inciting these acts, an accusation Israel has vehemently denied.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Eli Lilly (LLY) is actively combating the proliferation of fake and compounded versions of its popular weight-loss and [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5833,337,6761,1766,6991,4824,7442,7446,5015,10832,5016,10833,5039,10834,5215,5596,5775],"class_list":["post-53197","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-fda","tag-lly","tag-eli-lilly","tag-nsrgy","tag-trade-agreement","tag-geopolitics","tag-cepa","tag-mounjaro","tag-gaza","tag-zepbound","tag-israel","tag-nestle-2","tag-eu","tag-leadership-change","tag-un","tag-indonesia","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/53197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=53197"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/53197\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=53197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=53197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=53197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}